Detalhe da pesquisa
1.
The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69).
BJOG
; 131(7): e1-e30, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311315
2.
Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 × 2 Factorial Trial.
Ann Intern Med
; 176(7): 922-933, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335994
3.
Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy.
J Inherit Metab Dis
; 46(1): 129-142, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36225138
4.
Classical homocystinuria presenting with transient basal ganglia pathology and dystonia.
J Inherit Metab Dis
; 46(6): 1206-1208, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718464
5.
Infantile Spasms without Hypsarrhythmia and Paroxysmal Eye-Head Movements in an Infant with a Pyridoxine-Dependent Epilepsy due to PLPBP/PLPHP Deficiency.
Neuropediatrics
; 54(6): 422-425, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577449
6.
Current evidence for adjunct pyridoxine (vitamin B6) for the treatment of behavioral adverse effects associated with levetiracetam: A systematic review.
Epilepsy Behav
; 140: 109065, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791631
7.
Genetic assessment in primary hyperoxaluria: why it matters.
Pediatr Nephrol
; 38(3): 625-634, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695965
8.
Mechanisms of action of vitamin B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) in pain: a narrative review.
Nutr Neurosci
; 26(3): 235-253, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156556
9.
Vincristine-induced ptosis in a leukemia patient treated with pyridoxine and pyridostigmine.
J Oncol Pharm Pract
; 29(5): 1271-1274, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734133
10.
The effects of pyridoxine (vitamin B6) supplementation in nausea and vomiting during pregnancy: a systematic review and meta-analysis.
Arch Gynecol Obstet
; 308(4): 1075-1084, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719452
11.
Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy.
Mol Genet Metab
; 135(4): 350-356, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279367
12.
Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial.
Epilepsy Behav
; 136: 108938, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228485
13.
Pharmacological prevention strategy for capecitabine-induced hand-foot syndrome: A network meta-analysis of randomized control trials.
Dermatol Ther
; 35(10): e15774, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054263
14.
Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.
Support Care Cancer
; 30(11): 8655-8666, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35655045
15.
Pyridoxine or pyridoxal-5-phosphate treatment for seizures in glycosylphosphatidylinositol deficiency: A cohort study.
Dev Med Child Neurol
; 64(6): 789-798, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080266
16.
Pyridoxine-dependent Epilepsy caused by a Novel homozygous mutation in PLPBP Gene.
Metab Brain Dis
; 37(8): 3027-3032, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36308585
17.
Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
Am J Kidney Dis
; 77(5): 816-819, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891627
18.
Vitamin B status and association with antiseizure medication in pregnant women with epilepsy.
Epilepsia
; 62(12): 2968-2980, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590314
19.
Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
J Inherit Metab Dis
; 44(1): 178-192, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200442
20.
Cystathionine ß-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis.
J Inherit Metab Dis
; 44(3): 677-692, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295057